Tag: BioSyent

March 20, 2019

BioSyent Releases Results for Fourth Quarter and Full Year 2018

BioSyent (TSXV:RX) has announced its financial results for the three and 12 month period ended December 31, 2018. As quoted...
November 21, 2018

BioSyent’s Share Price Drops on Q3 Earnings

Rene Geohrum, CEO of BioSyent, said the decrease in international revenue was the result of “restrictions in a particular export...
November 21, 2018

BioSyent Releases Results for Third Quarter and First Nine Months of 2018

BioSyent (TSXV:RX) released today a summary of its financial results for the three and nine months ended September 30, 2018....
March 21, 2018

BioSyent Releases Results for Fourth Quarter and Full Year 2017

BioSyent (TSXV:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017....
February 5, 2018

5 Pharmaceutical Stocks on the TSX and TSXV

Opportunities abound when it comes to TSX pharmaceutical stocks, particularly those of the nano or micro cap variety, we're profiling...
May 25, 2017

BioSyent Posts Q1 2017 Financials

BioSyent released their financial results for the first quarter of 2017.
April 13, 2017

An Introduction to TSXV Life Science Stocks

Should you decide that the TSXV is right for you, the Investing News Network has compiled a list of some...